Objectives As some clinical trials may not capture utility data, the objective of this analysis
was to explore various statistical approaches and identify the best algorithm to predict EQ …

Objective The aim of this study was to develop a response mapping algorithm to predict EQ-
5D-5L utilities from European Organisation for Research and Treatment Quality of Life …

Objective The purpose of this research was to create a function for mapping the cancer-
specific instrument (FACT-G) to a preference-based measure (EQ-5D-3 L) utility index for …

Objectives: To estimate models, via ordinary least squares regression, for predicting Euro
Qol 5D (EQ‐5D), Short Form 6D (SF‐6D), and 15D utilities from scale scores of the …

Background To compare measurement properties of the utility scores derived from various
country-specific value sets of EQ-5D-5L (5L) and EORTC QLU-C10D (10D) in gastric cancer …

Objective: This study aims to develop a function for mapping the English and Chinese
versions of the Functional Assessment of Cancer Therapy–General (FACT–G) scores to the …

Objectives This study aimed to evaluate the cost-effectiveness of combination therapy of
nivolumab plus chemotherapy (FOLFOX or XELOX)(Niv+ Chemo) comparing with …

Purpose Patient-level utility data are needed for cost-utility analysis; in oncology, however,
the data are commonly gathered using disease-specific questionnaires that are often not …

Objectives There is growing interest in using condition-specific preference measures,
including the European Organization for Research and Treatment of Cancer Quality of Life …

Objectives Health technology assessments (HTAs) inform reimbursement decisions.
International differences in HTA processes lead to international differences in patient access …